| | Mean | Min.–Max. |
| Age | 66,4 | 53–74 | Weight (kg) | 79,9 | 53–141 | Height (cm) | 174,0 | 1,57–1,89 | Years of disease duration | 5,0 | 3–7 | Hoehn&Yahr | 2,2 | 2–3 | MoCa-score | 27,6 | 26–30 | Comorbidity | 1,4 | 1–5 |
| | N | % |
| Women | 18 | 53,0 | Men | 16 | 47,0 | Cohabiting | 25 | 73,0 | Living alone | 9 | 27,0 | Primary school [7–12] | 3 | 9,0 | Higher education | 25 | 73,0 | Vocational | 6 | 18,0 | Number of PD-drugs [1] | 2 | 6 | Number of PD-drugs [2, 3] | 32 | 94,0 | Number of PD-dosages [1, 2] | 10 | 29,4 | Number of PD-dosages [3, 4] | 24 | 70,6 |
| | Mean | Min.-Max. | MDS-UPDRS part II score | 12,92 (Median = 9) | 5–27 |
| # Item 1, 8 & 12 (3 selected items) | Median | Min.-Max. | Speech | 2,0 | 0–3 | Hobbies and other activities | 1,0 | 0–2 | Walking and balance | 1,0 | 0–3 |
|
|